Send Inquiry

Request To Call Back

Iclusig Ponatinib Tablets 45mg

Get a Price/Quote

MOQ : 50 Strips

Iclusig Ponatinib Tablets 45mg Specification

Salt Composition
Ponatinib hydrochloride

Origin of Medicine
Manufactured by Takeda Pharmaceuticals

Packaging Type
Box

Indication
Indicated for the treatment of chronic myeloid leukemia (CML) and Philadelphia chromosome positive acute lymphoblastic leukemia (Ph+ ALL)

Pacakaging (Quantity Per Box)
30 tablets

Life Span
See packaging for expiry date

Dosage Form
Oral tablet

Drug Type
Prescription only (Rx)

Ingredients
Ponatinib

Physical Form
Tablet

Function
Tyrosine kinase inhibitor for cancer treatment

Recommended For
Prescribed for patients with certain types of leukemia (CML and ALL)

Dosage
45 mg per tablet, as directed by healthcare provider

Dosage Guidelines
Swallow the tablets whole. Do not cut, crush, or dissolve the tablets. Follow physicians prescription

Suitable For
Adults, as prescribed

Quantity
30 tablets per box

Storage Instructions
Store at room temperature, keep in original packaging, away from moisture and heat

Usage
Cancer therapy for CML and Ph+ ALL under medical supervision

Brand Name
Iclusig

Marketed By
Takeda Pharmaceuticals

Caution
Dispense attached medication guide

NDC Number
NDC 64764-534-30

Strength
45 mg

Administration Route
Oral

Iclusig Ponatinib Tablets 45mg Trade Information

Minimum Order Quantity
50 Strips

Payment Terms
Cash in Advance (CID)

Supply Ability
1000 Strips Per Month

Delivery Time
2-5 Days

Main Domestic Market
All India

About Iclusig Ponatinib Tablets 45mg

Capitalise on exceptional cancer therapy with Iclusig Ponatinib Tablets 45mg-an outstanding solution designed to treat chronic myeloid leukemia (CML) and Philadelphia chromosome positive acute lymphoblastic leukemia (Ph+ ALL). This redoubtable oral medication, prescribed exclusively under medical supervision, features a special markdown for qualified healthcare procurement. Each tablet contains 45mg of Ponatinib, a potent tyrosine kinase inhibitor crafted by Takeda Pharmaceuticals. Supplied in a secure box of 30 tablets, Iclusig ensures patient safety with an attached medication guide and strict adherence to prescribed dosage, making it a cornerstone in innovative leukemia management.

Exceptional Features & Applications of Iclusig Ponatinib Tablets 45mg

Iclusig Ponatinib Tablets 45mg showcase outstanding efficacy as a targeted cancer therapy, primarily indicated for adults diagnosed with CML or Ph+ ALL. Key features include its robust tyrosine kinase inhibition, oral administration, and easy-to-dosage format. The product is plant-manufactured by Takeda Pharmaceuticals, ensuring high-quality standards. Additional features encompass comprehensive packaging-30 tablets per box, clear storage guidelines, and specific dosage instructions. Iclusig's redoubtable effect in patient care renders it essential in specialized oncology settings.

Sample Availability, Policy, and Export Market Reach

Iclusig Ponatinib Tablets 45mg samples are available on request, subject to a transparent sample policy. Completing orders is streamlined for both domestic and international clients, with shipped goods secured as per industry standards. The main export markets encompass robust domestic mar and growing global territories, supporting healthcare providers worldwide. Consistent fulfillment processes and reliable logistics ensure prompt order completion, allowing healthcare professionals to access this special medication efficiently and confidently.

FAQ's of Iclusig Ponatinib Tablets 45mg:

Q: How should Iclusig Ponatinib Tablets 45mg be administered for effective treatment?

A: Iclusig Ponatinib Tablets 45mg should be taken orally, exactly as directed by your healthcare provider. Swallow the tablets whole without cutting, crushing, or dissolving them. Always follow the prescribed dosage and the instructions in the attached medication guide.

Q: What is the primary benefit of using Iclusig Ponatinib for leukemia therapy?

A: The primary benefit of Iclusig Ponatinib lies in its exceptional ability to inhibit tyrosine kinases, making it highly effective in treating chronic myeloid leukemia (CML) and Ph+ acute lymphoblastic leukemia (Ph+ ALL) when standard treatments are unsuitable.

Q: When is Iclusig Ponatinib prescribed to patients?

A: Iclusig Ponatinib is prescribed by healthcare specialists for adult patients diagnosed with certain types of leukemia, specifically CML and Ph+ ALL, usually when other treatments have not been effective or are not well-tolerated.

Q: Where should Iclusig Ponatinib Tablets be stored after dispensing?

A: These tablets should be stored at room temperature, away from moisture and heat, and kept in their original packaging to maintain their stability and potency. Always ensure the packaging remains intact as specified.

Q: What precautions should be observed while using Iclusig Ponatinib Tablets?

A: It is crucial to dispense Iclusig with the attached medication guide. Only use under strict medical supervision, follow dosage guidelines carefully, and never modify or crush the tablets. Inform your physician of all medications you are taking to prevent interactions.

Q: How can healthcare providers order samples or complete an order for Iclusig Ponatinib?

A: Healthcare providers can request product samples by referencing the sample policy and placing orders via authorized supply chains. Both domestic and export markets are supported, ensuring prompt shipped goods and reliable order completion worldwide.

Tell us about your requirement

Price:

Quantity

Select Unit

50
100
200
250
500
1000+

Additional detail

Mobile number

More Products in Oncology And Targeted Cancer Therapies Medication Category

Iclusig Ponatinib Film-Coated Tablets 15mg

Minimum Order Quantity : 50 Boxes

Indication : Indicated for the treatment of adult patients with chronic phase, accelerated phase, or blast phase chronic myeloid leukemia (CML) or Philadelphia chromosomepositive acute lymphoblastic leukemia (Ph+ ALL) with resistance or intolerance to prior tyrosine kinase inhibitor therapy

Origin of Medicine : Pharmaceutical preparation

Packaging Type : Bottle in a box

Ingredients : Ponatinib

Storage Instructions : Store below 30C, in a dry place, protected from light

Get a Price/Quote